JGP Wealth Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$394K Sell
2,511
-25
-1% -$3.75K 0.04% 166
2026
Q1
$387K Buy
2,536
+106
+4% +$16.2K 0.04% 159
2025
Q4
$335K Buy
2,430
+618
+34% +$80.9K 0.03% 178
2025
Q3
$237K Buy
+1,812
New +$221K 0.03% 188
2018
Q3
Sell
-33,707
Closed -$2.28M 121
2018
Q2
$2.28M Buy
+33,707
New +$2.33M 0.95% 50

Other funds holding NVS

JGP Wealth Management's NVS Position: Q2 2026 in Review

JGP Wealth Management reduced its Novartis (NVS) stake by 0.99% in Q2 2026, selling an estimated $3.75K and leaving 2,511 shares worth $394K. The position accounts for 0.04% of the portfolio, ranked #166.

JGP Wealth Management first reported a position in NVS in Q2 2018 and has held it in 5 quarters since. The position peaked at $2.28M in Q2 2018. 557 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • JGP Wealth Management held 2,511 shares of Novartis worth $394K as of Q2 2026.
  • JGP Wealth Management sold 25 Novartis shares in Q2 2026, an estimated $3.75K.
  • Novartis made up 0.04% of JGP Wealth Management's portfolio in Q2 2026, its #166 holding.
  • JGP Wealth Management first reported a position in Novartis in Q2 2018 and has held it in 5 quarters since.
  • JGP Wealth Management's Novartis position peaked at $2.28M in Q2 2018.
  • 557 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on JGP Wealth Management's 13F filing for Q2 2026, filed 7 Jul 2026.